{"id":"https://openalex.org/W2014899753","doi":"https://doi.org/10.1161/01.cir.96.9.3072","title":"Synergistic Effects of ACE Inhibition and Ang II Antagonism on Blood Pressure, Cardiac Weight, and Renin in Spontaneously Hypertensive Rats","display_name":"Synergistic Effects of ACE Inhibition and Ang II Antagonism on Blood Pressure, Cardiac Weight, and Renin in Spontaneously Hypertensive Rats","publication_year":1997,"publication_date":"1997-11-04","ids":{"openalex":"https://openalex.org/W2014899753","doi":"https://doi.org/10.1161/01.cir.96.9.3072","mag":"2014899753","pmid":"https://pubmed.ncbi.nlm.nih.gov/9386177"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.96.9.3072","doi":"https://doi.org/10.1161/01.cir.96.9.3072","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.96.9.3072","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087581609","display_name":"Jo\u00ebl M\u00e9nard","orcid":"https://orcid.org/0000-0002-4507-2839","observed_orcids":["https://orcid.org/0000-0002-4507-2839"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]},{"id":"https://openalex.org/I77826658","display_name":"St Vincents Institute of Medical Research","ror":"https://ror.org/02k3cxs74","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I77826658"]}],"countries":["AU","FR"],"is_corresponding":false,"raw_author_name":"Joe\u0308l Me\u0301nard","raw_affiliation_strings":["From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210166329","https://openalex.org/I77826658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022682140","display_name":"Duncan John Campbell","orcid":"https://orcid.org/0000-0002-6896-7571","observed_orcids":["https://orcid.org/0000-0002-6896-7571"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]},{"id":"https://openalex.org/I77826658","display_name":"St Vincents Institute of Medical Research","ror":"https://ror.org/02k3cxs74","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I77826658"]}],"countries":["AU","FR"],"is_corresponding":false,"raw_author_name":"Duncan J. Campbell","raw_affiliation_strings":["From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)","Duncan J. Campbell From INSERM Unit 367, Paris, France (J.M., M.-F.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210166329","https://openalex.org/I77826658"]},{"raw_affiliation_string":"Duncan J. Campbell From INSERM Unit 367, Paris, France (J.M., M.-F.G.)","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059403921","display_name":"Michel Azizi","orcid":"https://orcid.org/0000-0003-0597-8318","observed_orcids":["https://orcid.org/0000-0003-0597-8318"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]},{"id":"https://openalex.org/I77826658","display_name":"St Vincents Institute of Medical Research","ror":"https://ror.org/02k3cxs74","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I77826658"]}],"countries":["AU","FR"],"is_corresponding":false,"raw_author_name":"Michel Azizi","raw_affiliation_strings":["From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)","Michel Azizi From INSERM Unit 367, Paris, France (J.M., M.-F.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210166329","https://openalex.org/I77826658"]},{"raw_affiliation_string":"Michel Azizi From INSERM Unit 367, Paris, France (J.M., M.-F.G.)","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110306693","display_name":"Marie-Fran\u00e7oise Gonzales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]},{"id":"https://openalex.org/I77826658","display_name":"St Vincents Institute of Medical Research","ror":"https://ror.org/02k3cxs74","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I77826658"]}],"countries":["AU","FR"],"is_corresponding":false,"raw_author_name":"Marie-Franc\u0327oise Gonzales","raw_affiliation_strings":["From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent\u2019s Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Ho\u0302pitaux de Paris and INSERM, Paris, France (M.A.)","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210166329","https://openalex.org/I77826658"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.0848,"has_fulltext":false,"cited_by_count":136,"citation_normalized_percentile":{"value":0.96779148,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"96","issue":"9","first_page":"3072","last_page":"3078"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-converting-enzyme-inhibition","display_name":"angiotensin-converting enzyme inhibition","score":0.7319999933242798},{"id":"https://openalex.org/keywords/angiotensin-ii-receptor-antagonism","display_name":"angiotensin II receptor antagonism","score":0.9810000061988831},{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":0.8109999895095825},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6600000262260437},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9589999914169312},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.765999972820282},{"id":"https://openalex.org/keywords/left-ventricular-hypertrophy","display_name":"left ventricular hypertrophy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/plasma-angiotensin-ii","display_name":"plasma angiotensin II","score":0.8420000076293945},{"id":"https://openalex.org/keywords/angiotensin-1-7","display_name":"angiotensin-(1-7)","score":0.890999972820282},{"id":"https://openalex.org/keywords/angiotensinogen","display_name":"angiotensinogen","score":0.9070000052452087},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.875}],"concepts":[{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.9666789770126343},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.9082409143447876},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.7276912927627563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7256491780281067},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7206127643585205},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.6435598731040955},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6377559900283813},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.611445426940918},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5849884152412415},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5252178311347961},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.44717806577682495},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.4375871419906616},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.42418766021728516},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3530312180519104},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.3508002758026123},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3371117115020752}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000809","descriptor_name":"Angiotensins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009929","descriptor_name":"Organ Size","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1161/01.cir.96.9.3072","doi":"https://doi.org/10.1161/01.cir.96.9.3072","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.96.9.3072","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:9386177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9386177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7599999904632568,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1516407063","https://openalex.org/W1964540813","https://openalex.org/W1971752121","https://openalex.org/W1975291885","https://openalex.org/W1978678404","https://openalex.org/W1989213644","https://openalex.org/W1990301821","https://openalex.org/W1999107098","https://openalex.org/W2003081992","https://openalex.org/W2005591623","https://openalex.org/W2010031713","https://openalex.org/W2018312583","https://openalex.org/W2022868918","https://openalex.org/W2041718175","https://openalex.org/W2042670046","https://openalex.org/W2043138008","https://openalex.org/W2044404050","https://openalex.org/W2045075125","https://openalex.org/W2061494383","https://openalex.org/W2067822797","https://openalex.org/W2079183193","https://openalex.org/W2092389955","https://openalex.org/W2093917387","https://openalex.org/W2104598696","https://openalex.org/W2128635872","https://openalex.org/W2129624401","https://openalex.org/W2131033837","https://openalex.org/W2131529339","https://openalex.org/W2134032718","https://openalex.org/W2138806344","https://openalex.org/W2144391460","https://openalex.org/W2154885779","https://openalex.org/W2169162350","https://openalex.org/W2171083892","https://openalex.org/W2198046790","https://openalex.org/W2223501982","https://openalex.org/W2330209657","https://openalex.org/W2397986337"],"related_works":["https://openalex.org/W2003081992","https://openalex.org/W2051866917","https://openalex.org/W2141807410","https://openalex.org/W2053760888","https://openalex.org/W2074522672","https://openalex.org/W2319980385","https://openalex.org/W2169162350","https://openalex.org/W2417390553","https://openalex.org/W2090940942","https://openalex.org/W1989213644"],"abstract_inverted_index":{"BACKGROUND:":[0],"Blockade":[1],"of":[2,17,62,65,95,146,174,177,192,221],"type":[3],"1":[4],"angiotensin":[5],"(Ang)":[6],"II":[7,32,135,142,157,217,224,236,246],"receptors":[8],"combined":[9],"with":[10,85,148,160,240],"ACE":[11,23,211],"inhibition":[12,191],"may":[13],"amplify":[14],"the":[15,18,86,153,168,172,193,210,222,233,241,244],"efficacy":[16],"renin-angiotensin":[19,194],"system":[20,195],"blockade":[21],"because":[22],"inhibitors":[24],"do":[25],"not":[26],"completely":[27],"and":[28,43,75,98,114,117,121,124,137,179,183],"permanently":[29],"suppress":[30],"Ang":[31,122,134,141,156,216,223,229,235,245],"production.":[33],"METHODS":[34],"AND":[35],"RESULTS:":[36],"Enalapril":[37,130],"or":[38,46,88,151],"losartan":[39,138,149,161,180],"(1,":[40],"3,":[41],"10,":[42],"30":[44],"mg/kg)":[45],"their":[47,99,197],"combination":[48,61,145,198],"was":[49],"administered":[50],"for":[51,243],"2":[52],"to":[53,56,188],"4":[54],"weeks":[55],"spontaneously":[57],"hypertensive":[58],"rats.":[59],"The":[60,144],"low":[63,175],"doses":[64,176],"each":[66],"agent":[67,202],"induced":[68],"greater":[69],"reductions":[70,126],"in":[71,112,118,127,155,214,219,228],"blood":[72],"pressure":[73],"(BP)":[74],"left":[76],"ventricular":[77],"weight/body":[78],"weight":[79],"(LVW/":[80],"BW)":[81],"ratio":[82,185],"than":[83,199],"monotherapy":[84],"same":[87],"higher":[89],"doses.":[90],"When":[91,204],"approximately":[92],"equipotent":[93],"regimens":[94],"enalapril,":[96],"losartan,":[97],"combination,":[100],"as":[101],"judged":[102],"by":[103,196,200],"BP":[104,182],"fall,":[105],"were":[106,109],"compared,":[107],"there":[108],"similar":[110,125],"increases":[111],"plasma":[113,119,128,133,215,234],"renal":[115],"renin":[116],"Ang-(1-7)":[120],"I":[123],"angiotensinogen.":[129],"alone":[131,139],"reduced":[132,152],"levels,":[136],"increased":[140],"levels.":[143],"enalapril":[147,178],"prevented":[150],"increase":[154],"levels":[158],"observed":[159],"alone.":[162,203],"CONCLUSIONS:":[163],"These":[164],"findings":[165],"show":[166],"that":[167],"synergistic":[169],"interaction":[170],"between":[171],"effects":[173],"on":[181],"LVW/BW":[184],"is":[186],"due":[187],"more":[189],"effective":[190],"either":[201],"both":[205],"drugs":[206],"are":[207],"given":[208],"together,":[209],"inhibitor-induced":[212],"fall":[213],"results":[218],"modulation":[220],"antagonist-induced":[225],"reactive":[226],"rise":[227],"II,":[230],"thereby":[231],"lowering":[232],"concentration,":[237],"which":[238],"competes":[239],"antagonist":[242],"receptors.":[247]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}